-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
C4 Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q2 2024.
- C4 Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$21.4M, a 42.9% increase year-over-year.
- C4 Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$119M, a 17.8% increase year-over-year.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$139M, a 7.33% decline from 2022.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$130M, a 57.7% decline from 2021.
- C4 Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$82.1M, a 35.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)